These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 36178158)

  • 1. The emerging microbiome-based approaches to IBD therapy: From SCFAs to urolithin A.
    Rudiansyah M; Abdalkareem Jasim S; S Azizov B; Samusenkov V; Kamal Abdelbasset W; Yasin G; Mohammad HJ; Jawad MA; Mahmudiono T; Hosseini-Fard SR; Mirzaei R; Karampoor S
    J Dig Dis; 2022 Aug; 23(8-9):412-434. PubMed ID: 36178158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gut microbiota in the pathogenesis of inflammatory bowel disease.
    Nishida A; Inoue R; Inatomi O; Bamba S; Naito Y; Andoh A
    Clin J Gastroenterol; 2018 Feb; 11(1):1-10. PubMed ID: 29285689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of the fecal microbiota in inflammatory bowel disease.
    Khalaf R; Sciberras M; Ellul P
    Eur J Gastroenterol Hepatol; 2024 Nov; 36(11):1249-1258. PubMed ID: 38973540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can control of gut microbiota be a future therapeutic option for inflammatory bowel disease?
    Nishida A; Nishino K; Sakai K; Owaki Y; Noda Y; Imaeda H
    World J Gastroenterol; 2021 Jun; 27(23):3317-3326. PubMed ID: 34163114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The emerging role of the gut microbiota and its application in inflammatory bowel disease.
    Wang X; Peng J; Cai P; Xia Y; Yi C; Shang A; Akanyibah FA; Mao F
    Biomed Pharmacother; 2024 Oct; 179():117302. PubMed ID: 39163678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The microbiome and inflammatory bowel disease.
    Glassner KL; Abraham BP; Quigley EMM
    J Allergy Clin Immunol; 2020 Jan; 145(1):16-27. PubMed ID: 31910984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic Advances in Gut Microbiome Modulation in Patients with Inflammatory Bowel Disease from Pediatrics to Adulthood.
    Eindor-Abarbanel A; Healey GR; Jacobson K
    Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cross-talk between macrophages and gut microbiota in inflammatory bowel disease: a dynamic interplay influencing pathogenesis and therapy.
    Ning S; Zhang Z; Zhou C; Wang B; Liu Z; Feng B
    Front Med (Lausanne); 2024; 11():1457218. PubMed ID: 39355844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inflammatory Bowel Diseases (IBD) and the Microbiome-Searching the Crime Scene for Clues.
    Lee M; Chang EB
    Gastroenterology; 2021 Jan; 160(2):524-537. PubMed ID: 33253681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Microbiome as a Therapy in Pouchitis and Ulcerative Colitis.
    LeBlanc JF; Segal JP; de Campos Braz LM; Hart AL
    Nutrients; 2021 May; 13(6):. PubMed ID: 34071065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inflammatory Bowel Diseases and Gut Microbiota.
    Haneishi Y; Furuya Y; Hasegawa M; Picarelli A; Rossi M; Miyamoto J
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Gut Microbiome and Inflammatory Bowel Diseases.
    Shan Y; Lee M; Chang EB
    Annu Rev Med; 2022 Jan; 73():455-468. PubMed ID: 34555295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Review article: the gut microbiome in inflammatory bowel disease-avenues for microbial management.
    McIlroy J; Ianiro G; Mukhopadhya I; Hansen R; Hold GL
    Aliment Pharmacol Ther; 2018 Jan; 47(1):26-42. PubMed ID: 29034981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nutritional Support and Probiotics as a Potential Treatment of IBD.
    Tarasiuk A; Eibl G
    Curr Drug Targets; 2020; 21(14):1417-1427. PubMed ID: 32364071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disturbances of the Gut Microbiota and Microbiota-Derived Metabolites in Inflammatory Bowel Disease.
    Hu Y; Chen Z; Xu C; Kan S; Chen D
    Nutrients; 2022 Dec; 14(23):. PubMed ID: 36501169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic modulation of gut microbiota in inflammatory bowel disease: More questions to be answered.
    Qiao YQ; Cai CW; Ran ZH
    J Dig Dis; 2016 Dec; 17(12):800-810. PubMed ID: 27743467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inflammatory bowel disease biomarkers of human gut microbiota selected via different feature selection methods.
    Bakir-Gungor B; Hacılar H; Jabeer A; Nalbantoglu OU; Aran O; Yousef M
    PeerJ; 2022; 10():e13205. PubMed ID: 35497193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Emerging Role of Bile Acids in the Pathogenesis of Inflammatory Bowel Disease.
    Thomas JP; Modos D; Rushbrook SM; Powell N; Korcsmaros T
    Front Immunol; 2022; 13():829525. PubMed ID: 35185922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intestinal microbiota, fecal microbiota transplantation, and inflammatory bowel disease.
    Weingarden AR; Vaughn BP
    Gut Microbes; 2017 May; 8(3):238-252. PubMed ID: 28609251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microbiota in Inflammatory Bowel Disease Pathogenesis and Therapy: Is It All About Diet?
    Serban DE
    Nutr Clin Pract; 2015 Dec; 30(6):760-79. PubMed ID: 26452390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.